Landkin Biological: Accelerate the development of new quality productivity to ignite a
new engine of high-quality development
Hunan Langde Jinyuan Biotechnology Co., Ltd. has settled in Anxiang High-tech
Industrial Development Zone since July last year, relying on its own scientific and
technological innovation ability, to promote the deep transformation and upgrading
of the industry, and ignite the new engine of high-quality development of the county
economy.
In the laboratory of the pilot plant of Lande, technicians are operating experimental
instruments, large and small "bottles and cans" containing groups of raw materials, they
through synthetic biotechnology, biological raw materials after a series of processes such
as reasonable design, structure, fermentation, will produce functional components with
high value.
Hunan Langde Jinyuan Biotechnology Co., Ltd. technical staff Liu Jian We are now
developing is the cosmetic raw material bosin, now the pilot has been completed,
about October production, its substrate catalytic concentration can reach 70 grams
per liter, the conversion rate can reach more than 90%.
The product development direction of LandeJinyuan Biological is mainly the rare
components of rare plants produced by synthetic biology technology. This technology
can significantly reduce the planting area, shorten the production cycle, reduce water
consumption and carbon emissions, and can avoid the shortage of raw material sources,
make the production process more stable and sustainable, and achieve large-scale
production of rare ingredients.
Synthetic biology is a multi-disciplinary, the use of synthetic biology technology can
produce food, cosmetics, pharmaceutical intermediates, new materials, alternative
petrochemical and other products, more than 60% of the world's products can be
produced by such technology, the main feature is low carbon emissions and not
limited by raw materials.
Emerging technologies such as artificial intelligence and gene editing are being used
in Landkin's research and development projects. By enhancing the innovation ability of
biotechnology and strengthening the original and leading basic research, Landgold
Bio-has independently developed more than 20 production technologies such as NMN,
A-arbutin and resveratrol.
The key to the development of synthetic biotechnology is the construction of biological
components and high-throughput screening, and the establishment of enzyme selective,
constitutive, enzyme-producing and enzyme-using AI circulation system.
Landejinyuan Biological has a professional product research and development team, and
has a wide range of contacts and exchanges with domestic and foreign scientific research
institutions, to build AAS, GC, LC-MS and other quality testing platforms, chemical
synthesis, separation and purification research and development platforms, to supply a
variety of high-quality and inexpensive API products for the market.
Wu Xinming, general manager of Hunan Lande Jinyuan Biotechnology Co., Ltd. now
produces NMN series, bilirubin, bose, coenzyme Q10 and other products, mainly sold
to Hunan Dibo, Wuhan Wang Shuhe and other companies, the products are mainly used
in health food, cosmetics, pharmaceutical products, purity can reach 99.9% or more,
impurity content is low, organic residue is low. It has an absolute cost advantage.
Hunan Lande Jinyuan Biotechnology Co., Ltd. invested 50 million yuan, is one of the key
projects of Anxiang County investment, the company covers an area of 21,000 square
meters, has built enzyme and engineering bacteria experiment platform, fermentation
enzyme workshop, NMN and other system product purification and separation workshop.
Wu Xinming, general manager of Hunan Langde Jinyuan Biotechnology Co., LTD., the
construction of the production line is to take the water circulation system, reduce the
discharge of water, the main feature of the process is to replace the chemical reaction.
With new quality productivity based on scientific and technological innovation,
LandeJinyuan Biological has established a long-term and stable cooperative partnership
with the world's top pharmaceutical companies, and its products radiate to Asia, North
America and Europe. The company now has an annual output capacity of 200 tons, with
an annual output value of more than 150 million yuan, according to market demand,
LandeJinyuan Biological is carrying out the construction of the second production line,
and the annual output value can reach more than 500 million yuan after completion.
We will find ways to solve and improve these tasks.
● Anxiang County held a key work scheduling meeting
● The county optimization business environment work promotion meeting was held
● All units in Anxiang County convey and study the spirit of the Third Plenary Session of
the 20th CPC Central Committee (2)
Anxiang financial media: Liu Haibo Jian Mengsi
Editor: Guo Jing
The first instance: Zhang Jiong The second instance: Lu Zhi The third instance: Huang Wei
Chief Producer: Xiao Ping